BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25700553)

  • 1. The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.
    Sakurai K; Reon BJ; Anaya J; Dutta A
    Mol Cancer Res; 2015 May; 13(5):828-38. PubMed ID: 25700553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
    Malik R; Patel L; Prensner JR; Shi Y; Iyer MK; Subramaniyan S; Carley A; Niknafs YS; Sahu A; Han S; Ma T; Liu M; Asangani IA; Jing X; Cao X; Dhanasekaran SM; Robinson DR; Feng FY; Chinnaiyan AM
    Mol Cancer Res; 2014 Aug; 12(8):1081-7. PubMed ID: 25030374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaced roles of the long non-coding RNA DRAIC in cancer progression.
    Sakurai K; Ito H
    Life Sci; 2024 Apr; 343():122544. PubMed ID: 38458555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation.
    Saha S; Kiran M; Kuscu C; Chatrath A; Wotton D; Mayo MW; Dutta A
    Cancer Res; 2020 Mar; 80(5):950-963. PubMed ID: 31900260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressive long noncoding RNA DRAIC inhibits protein translation and induces autophagy by activating AMPK.
    Saha S; Zhang Y; Wilson B; Abounader R; Dutta A
    J Cell Sci; 2021 Dec; 134(24):. PubMed ID: 34746949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.
    Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S
    Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5.
    Zhang Z; Hu X; Kuang J; Liao J; Yuan Q
    Cell Mol Biol Lett; 2020; 25():29. PubMed ID: 32351584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
    Colditz J; Rupf B; Maiwald C; Baniahmad A
    Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
    Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
    Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol.
    Al Aameri RFH; Sheth S; Alanisi EMA; Borse V; Mukherjea D; Rybak LP; Ramkumar V
    PLoS One; 2017; 12(5):e0177198. PubMed ID: 28467474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LncRNA DRAIC regulates the proliferation, apoptosis, migration and invasion of lung adenocarcinoma cells by targeting let-7i-5p].
    Liu BL; Cui YS; Tian YP; Zhu YZ; Hong ZQ; Zhang XM; Sun GG
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):471-481. PubMed ID: 37355465
    [No Abstract]   [Full Text] [Related]  

  • 16. DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP.
    Li S; Jia H; Zhang Z; Wu D
    Cancer Gene Ther; 2022 Jul; 29(7):951-960. PubMed ID: 34645975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.
    Misawa A; Takayama K; Urano T; Inoue S
    J Biol Chem; 2016 Aug; 291(34):17861-80. PubMed ID: 27342777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA DRAIC acts as a microRNA-122 sponge to facilitate nasopharyngeal carcinoma cell proliferation, migration and invasion via regulating SATB1.
    Liao B; Wang Z; Zhu Y; Wang M; Liu Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3585-3597. PubMed ID: 31497998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.
    Singh N; Ramnarine VR; Song JH; Pandey R; Padi SKR; Nouri M; Olive V; Kobelev M; Okumura K; McCarthy D; Hanna MM; Mukherjee P; Sun B; Lee BR; Parker JB; Chakravarti D; Warfel NA; Zhou M; Bearss JJ; Gibb EA; Alshalalfa M; Karnes RJ; Small EJ; Aggarwal R; Feng F; Wang Y; Buttyan R; Zoubeidi A; Rubin M; Gleave M; Slack FJ; Davicioni E; Beltran H; Collins C; Kraft AS
    Nat Commun; 2021 Dec; 12(1):7349. PubMed ID: 34934057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
    Liu Z; Yang S; Zhou S; Dong S; Du J
    Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.